Jagsonpal Pharmaceuticals Limited – NSE:JAGSNPHARM.NS

Jagsonpal Pharmaceuticals Limited stock price today

INR 179.1
-460.54
-72%
Financial Health
0
1
2
3
4
5
6
7
8
9

Jagsonpal Pharmaceuticals Limited stock price monthly change

+77.68%
month

Jagsonpal Pharmaceuticals Limited stock price quarterly change

+77.68%
quarter

Jagsonpal Pharmaceuticals Limited stock price yearly change

+65.22%
year

Jagsonpal Pharmaceuticals Limited key metrics

Market Cap
 17.16B
Enterprise value
 16.89B
P/E
 70.31
EV/Sales
 7.44
EV/EBITDA
 45.15
Price/Sales
 7.48
Price/Book
 8.66
PEG ratio
 -1.92
EPS
 8.52
Revenue
 2.08B
EBITDA
 298.59M
Income
 224.63M
Revenue Q/Q
 -21.58%
Revenue Y/Y
 -11.83%
Profit margin
 10.71%
Oper. margin
 13.61%
Gross margin
 38.48%
EBIT margin
 13.61%
EBITDA margin
 14.31%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Jagsonpal Pharmaceuticals Limited stock price history

Jagsonpal Pharmaceuticals Limited stock forecast

Jagsonpal Pharmaceuticals Limited financial statements

Profit Margin

Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM.NS): Profit margin
Jun 2023 601.53M 74.79M 12.43%
Sep 2023 578.29M 74.72M 12.92%
Dec 2023 472.34M 39.63M 8.39%
Mar 2024 434.86M 35.49M 8.16%
JAGSNPHARM.NS income statement history
0.78%
Yield TTM
Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM.NS): Payout ratio
Payout ratio 0%
Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM.NS): Dividend Yield
2016 0.31%
2017 0.32%
2019 0.93%
2020 2.85%
2022 1.28%
JAGSNPHARM.NS dividends history

Debt to Assets

Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM.NS): Debt to assets
Jun 2023 0 0
Sep 2023 2094000000 399.95M 19.1%
Dec 2023 0 0
Mar 2024 2170780000 296.76M 13.67%
JAGSNPHARM.NS balance sheet history

Cash Flow

Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM.NS): Cash Flow
Jun 2023 42.03M 0 0
Sep 2023 50.91M 0 0
Dec 2023 8.24M 0 0
Mar 2024 0 0 0
JAGSNPHARM.NS cash flow history

Jagsonpal Pharmaceuticals Limited alternative data

Jagsonpal Pharmaceuticals Limited
Employees

Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM.NS): Employee count
Sep 2023 940
Oct 2023 940
Nov 2023 940
Dec 2023 940
Jan 2024 940
Feb 2024 940
Mar 2024 940
Apr 2024 940
May 2024 940
Jun 2024 940
Jul 2024 940

Jagsonpal Pharmaceuticals Limited other data

Frequently Asked Questions (FAQ)

  • What's the price of Jagsonpal Pharmaceuticals Limited stock today?

    One share of Jagsonpal Pharmaceuticals Limited stock can currently be purchased for approximately $179.1.

  • When is Jagsonpal Pharmaceuticals Limited's next earnings date?

    Unfortunately, Jagsonpal Pharmaceuticals Limited's (JAGSNPHARM.NS) next earnings date is currently unknown.

  • Does Jagsonpal Pharmaceuticals Limited pay dividends?

    Yes, Jagsonpal Pharmaceuticals Limited pays dividends and its trailing 12-month yield is 0.78% with 0% payout ratio. The last Jagsonpal Pharmaceuticals Limited stock dividend of $0 was paid on 4 Sep 2025.

  • How much money does Jagsonpal Pharmaceuticals Limited make?

    Jagsonpal Pharmaceuticals Limited has a market capitalization of 17.16B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 7.69% to 2.09B US dollars.

  • What is Jagsonpal Pharmaceuticals Limited's stock symbol?

    Jagsonpal Pharmaceuticals Limited is traded on the NSE under the ticker symbol "JAGSNPHARM.NS".

  • What is Jagsonpal Pharmaceuticals Limited's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Jagsonpal Pharmaceuticals Limited?

    Shares of Jagsonpal Pharmaceuticals Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Jagsonpal Pharmaceuticals Limited have?

    As Jul 2024, Jagsonpal Pharmaceuticals Limited employs 940 workers.

  • When Jagsonpal Pharmaceuticals Limited went public?

    Jagsonpal Pharmaceuticals Limited is publicly traded company for more then 23 years since IPO on 1 Jul 2002.

  • What is Jagsonpal Pharmaceuticals Limited's official website?

    The official website for Jagsonpal Pharmaceuticals Limited is jagsonpal.com.

  • How can i contact Jagsonpal Pharmaceuticals Limited?

    Jagsonpal Pharmaceuticals Limited can be reached via phone at +91 11 4618 1100.

Jagsonpal Pharmaceuticals Limited company profile:

Jagsonpal Pharmaceuticals Limited

jagsonpal.com
Exchange:

NSE

Full time employees:

1,025

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Jagsonpal Pharmaceuticals Limited develops and manufactures bulk drugs and pharmaceutical formulations in the areas of women health, pain and analgesics, and general medicine. It offers general medicines, such as allergy management, immunity and cell protection, gut and mind management, anti-infectives, and dentist and ENT range products; and women's healthcare products, including pregnancy care, and dysfunctional uterine bleeding complications and management products. The company also provides pain and analgesics products in the areas of pain management, and bone and joint care. It offers drugs in the form of tablets, capsules, and syrups. The company was founded in 1964 and is based in New Delhi, India. Jagsonpal Pharmaceuticals Limited is a subsidiary of Aresko Progressive Private Limited.

+91 11 4618 1100
T-210 J, Shahpur Jat
New Delhi, 110049

:
ISIN: INE048B01027
CUSIP: Y4252X131